Skip to Main Content

Paper Details

Immune checkpoint inhibitors and timing of administration - Authors' reply.
Lancet Oncol
2
2022
Author NameAffiliation
David C QianWinship Cancer Institute of Emory University
  • 1 - 1

Datasets

Release 1.2